Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matilde Inglese

Showing results (281-290 of 315) with videos related to

Pageof 32
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|November 10, 2021
COVID-19 Severity in Multiple Sclerosis: Putting Data Into ContextMaria Pia Sormani, Irene Schiavetti, Luca Carmisciano, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 10, 2026
Task-oriented virtual reality and brain functional plasticity in progressive multiple sclerosis: A randomized controlled trial on upper limb rehabilitationMehrnaz Hamedani, Giada Lombardi, Giacomo Boffa, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2022
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patientsGisella Guerrera, Alessandra Mandelli, Annamaria Finardi, et al.
European Journal of Neurology|November 4, 2021
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosisRoberto Bergamaschi, Marta Ponzano, Irene Schiavetti, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 19, 2020
Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factorsPietro Iaffaldano, Giuseppe Lucisano, Francesco Patti, et al.
Nature Reviews. Neurology|January 15, 2025
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder - recommendations from ECTRIMS and the EBMTPaolo A Muraro, Alice Mariottini, Raffaella Greco, et al.
Annals of Clinical and Translational Neurology|July 6, 2024
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosisPietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, et al.
Annals of Clinical and Translational Neurology|July 7, 2025
Early Intensive Versus Escalation Approach: Ten-Year Impact on Disability in Relapsing Multiple SclerosisPietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, et al.
Cell Reports|November 13, 2025
Noradrenergic control of bone marrow and thymus by AgRP neurons is impaired in experimental multiple sclerosisTiziana Vigo, Maria C Mariani, Caterina Bason, et al.
Journal of the Neurological Sciences|May 15, 2025
Safety assessment of switching from fingolimod to siponimod: An Italian multicenter prospective studyGianmarco Abbadessa, Irene Schiavetti, Luca Bollo, et al.
Pageof 32

Showing results (281-290 of 315) with videos related to

Sort By:
Pageof 32
Neurology(R) Neuroimmunology & Neuroinflammation|November 10, 2021
COVID-19 Severity in Multiple Sclerosis: Putting Data Into ContextMaria Pia Sormani, Irene Schiavetti, Luca Carmisciano, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 10, 2026
Task-oriented virtual reality and brain functional plasticity in progressive multiple sclerosis: A randomized controlled trial on upper limb rehabilitationMehrnaz Hamedani, Giada Lombardi, Giacomo Boffa, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2022
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patientsGisella Guerrera, Alessandra Mandelli, Annamaria Finardi, et al.
European Journal of Neurology|November 4, 2021
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosisRoberto Bergamaschi, Marta Ponzano, Irene Schiavetti, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 19, 2020
Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factorsPietro Iaffaldano, Giuseppe Lucisano, Francesco Patti, et al.
Nature Reviews. Neurology|January 15, 2025
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder - recommendations from ECTRIMS and the EBMTPaolo A Muraro, Alice Mariottini, Raffaella Greco, et al.
Annals of Clinical and Translational Neurology|July 6, 2024
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosisPietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, et al.
Annals of Clinical and Translational Neurology|July 7, 2025
Early Intensive Versus Escalation Approach: Ten-Year Impact on Disability in Relapsing Multiple SclerosisPietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, et al.
Cell Reports|November 13, 2025
Noradrenergic control of bone marrow and thymus by AgRP neurons is impaired in experimental multiple sclerosisTiziana Vigo, Maria C Mariani, Caterina Bason, et al.
Journal of the Neurological Sciences|May 15, 2025
Safety assessment of switching from fingolimod to siponimod: An Italian multicenter prospective studyGianmarco Abbadessa, Irene Schiavetti, Luca Bollo, et al.
Pageof 32